The pharma companies will make the compounds – along with toxicity, dosing and biomarker data – available to interested researchers...The pharma companies would then have first rights at licensing that IP

But Marshall is optimistic that the company will be able to make good on anti-miR-208's potential, partly because the antagomir is partnered with French pharma company Les Laboratoires Servier. (See BioWorld Today, Oct. 19, 2011.) And the study confirmed what miRagen and others in the miRNA space believe about the powers of RNAi approach

Although the market for minimally invasive cosmetic procedures is dominated by products like Botox and wrinkle fillers, biotechs and pharma companies are gaining a bigger foothold. (See BioWorld Today, April 26, 2011.) In June 2011, for example, Fibrocell Sciences Inc.'s LaViv (azficel-T) was approved by the FDA to reduce the appearance of moderate to severe nasolabial fold wrinkles, commonly known as smile lines. (See BioWorld Today, June 23, 2011.) The technology developed by Exton, Pa.-based

Amgen Acquires Turkish Pharma Company One of Bradway's biggest priorities for Amgen going forward is to expand internationally, particularly into countries where it does not currently have a presence

While other pharma companies might be interested in HGSI, GSK would prove the best fit, J.P. Morgan analyst Cory Kasimov said

miRagen has products in late preclinical stages for chronic heart failure and post-myocardial infarction remodeling, which are partnered with French pharma company Les Laboratoires Servier, and it is investigating other therapies in indications related to cardiovascular and muscle disease and polycythemia vera

Large pharma companies already have that large sales force in place, which can add a new drug to a list it is already selling

MRC Technology has built its reputation by successfully commercializing the MRC's IP, while "it's clear that the existing model by which pharma companies turn research into products isn't working," Johnson said...As far as university IP is concerned, MRC Technology has an inside edge because it is talking to pharma companies regularly

Similar cases have been filed against virtually every major pharma company in the country, Lee Schreter, co-chair of the wage and hour practice at Littler Mendelson, told BioWorld Today

By Nuala Moran Staff Writer LONDON – Newron Pharmaceuticals SpA has found a new partner for its Phase III drug safinamide, securing a €20 million (US$26.1 million) opening payment, with milestones and royalties to come, from the Italian pharma company Zambon SpA...If it does so, the Milan-based pharma company will make a further undisclosed up-front payment and Newron will be eligible for regulatory milestones upon FDA and European Medicines Agency filings and approvals, plus double-digit royalties

LONDON – Newron Pharmaceuticals SpA has found a new partner for its Phase III drug safinamide, securing a €20 million (US$26.1 million) opening payment, with milestones and royalties to come, from the Italian pharma company Zambon SpA...If it does so, the Milan-based pharma company will make a further undisclosed up-front payment and Newron will be eligible for regulatory milestones upon FDA and European Medicines Agency filings and approvals, plus double-digit royalties on sales

To keep from being dragged over the cliff along with their drugs, pharma companies are digging in their heels...At the Edge of the Cliff Pfizer is not the only big pharma company standing at the edge of the patent cliff

LONDON – Newron Pharmaceuticals SpA has found a new partner for its Phase III drug safinamide, securing a €20 million (US$26.1 million) opening payment, with milestones and royalties to come, from the Italian pharma company Zambon SpA...If it does so, the Milan-based pharma company will make a further undisclosed up-front payment and Newron will be eligible for regulatory milestones upon FDA and European Medicines Agency filings and approvals, plus double-digit royalties on sales

Third Rock's large staff also allows it to build an internal pipeline, much like a biotech or pharma company

Third Rock's large staff also allows it to build an internal pipeline, much like a biotech or pharma company

with an unnamed specialty pharma company

While opening those therapies to generic competition and, thus, lower prices, the patent expirations mean major pharma companies will have less money for R&D. In the past, companies compensated for that loss of revenue by raising the prices on other drugs

with an unnamed specialty pharma company

Company (Location) Funding Institution Amount (US$M) Type Details (Date) AUGUST Celsion Corp. (Columbia, Md.) New Jersey Economic Development Authority $1.2 Business Employment Incentive Program grant For the company's relocation to Lawrenceville, N.J. DelMar Pharmaceuticals (Vancouver, British Columbia) National Research Council of Canada Industrial Research Assistance Program ND Grant To support study of the molecular mechanism of VAL-083, a candidate for glioblastoma multiforme (8/5) GeoVax